Cita APA

Cuyàs, E., Gumuzio, J., Verdura, S., Brunet, J., Bosch Barrera, J., Martín Castillo, B., . . . Menendez, J. A. (2020). The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: A potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes.

Citación estilo Chicago

Cuyàs, Elisabet, et al. The LSD1 Inhibitor Iadademstat (ORY-1001) Targets SOX2-driven Breast Cancer Stem Cells: A Potential Epigenetic Therapy in Luminal-B and HER2-positive Breast Cancer Subtypes. 2020.

Cita MLA

Cuyàs, Elisabet, et al. The LSD1 Inhibitor Iadademstat (ORY-1001) Targets SOX2-driven Breast Cancer Stem Cells: A Potential Epigenetic Therapy in Luminal-B and HER2-positive Breast Cancer Subtypes. 2020.